Surgical resection of liver metastases of colorectal carcinoma: Short and long-term results

Seminars in Oncology

Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 112-119

  Lorenz, M ^a   Staib Sebler, E ^a   Hochmuth, K ^a   Heinrich, S ^a   Gog, C ^a   Vetter, G ^a   Encke, A ^a   Muller, H H ^a  

^a Dept of General and Vascular Surg ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONFERENCE PAPER; HUMAN; LIVER METASTASIS; LIVER RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURGICAL APPROACH; SURGICAL RISK; TREATMENT INDICATION;

CLINICAL TRIALS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMAN; LIVER NEOPLASMS; PROGNOSIS; RISK;

EID: 0033786941     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Cancer statistics, 1997
2. Failure patterns following curative resection of colonic carcinoma
3. Neoplasms of the liver
4. Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
5. Liver metastases from colorectal carcinoma: Incidence, resectability, and survival results
6. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection based on 1568 patients. Association Francaise de Chirurgie
7. Resection of colorectal liver metastases
8. Resection of hepatic metastases from colorectal cancer
9. Liver resection for colorectal metastases
10. Liver resections of metastases of non-colorectal primary tumors
11. Vergleich der Ergebnisse und der Prognosefaktoren bei 627 Leberresektionen wegen kolorektaler und nicht-kolorektaler Metastasen
12. Hepatic resection for noncolorectal non-neuroendocrine metastases
13. Ein Fall von Resection eines linksseitigen Schnurlappens der Leber-Heilung
14. Natural history of patients with untreated liver metastases from colorectal cancer
15. Factors influencing the natural history of colorectal liver metastases
16. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive
17. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment
18. Resection of liver metastases from a colorectal carcinoma does not benefit the patient
19. Resection of liver metastases from colorectal cancer: The real impact of the surgical margin
20. Determinants of survival in liver resection for colorectal secondaries
21. Late results justify resection for multiple hepatic metastases from colorectal cancer
22. Segment-oriented liver resection. Principles-technique-status
23. The role of surgical resection of liver metastases in colorectal carcinoma
24. Sequential hepatic and pulmonary resections for metastatic colorectal cancer
25. Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: Evaluation with postoperative follow-up results
26. Impact of intraoperative ultrasonography on treatment strategy for colorectal cancer
27. Does intraoperative hepatic ultrasonography change surgical decision making during liver resection?
28. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use
29. Preoperative risk assessment of malignant disease
30. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study
31. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis
32. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence
33. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery
34. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)
35. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie
36. Current perspectives on repeat hepatic resection for colorectal carcinoma: A review
37. Repeat hepatectomy for colorectal liver metastases
38. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
39. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C- 03
40. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Treatment by hepatic resection
41. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival
42. Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases - A pilot study
43. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases
44. Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease
45. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study
46. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver
47. Local and systemic toxicity of intra-hepatic-arterial 5FU and high-dose or low dose leucovorin for liver metastases of colorectal cancer
48. Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver
49. A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver
50. The value of postoperative hepatic arterial infusion following curative liver resection
51. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
52. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
53. Perioperative predictors of morbidity following hepatic resection for neoplasm
54. Morbidity and mortality after hepatic resection of metastases from colorectal cancer
55. Results of 280 liver resections for hepatocellular carcinoma
56. Operative risks of major hepatic resections